Metabolomics Core
代谢组学核心
基本信息
- 批准号:10262784
- 负责人:
- 金额:$ 110.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:BacteriaBiochemicalBiologicalBiological MarkersBiopsyBloodCancer DetectionCancer ModelCarcinogenesis MechanismCellsChemicalsChillsClinicalCoiled BodiesCore FacilityCustomData CollectionDetectionDevelopmentDoseElectrospray IonizationEquipmentFutureGoalsHousingHumanImmune systemInfusion proceduresIonsIsotopesLaboratoriesLeadMagnetic Resonance SpectroscopyMammalsMass Spectrum AnalysisMetabolicMetabolismMethodologyMethodsMonitorNMR SpectroscopyNuclearOperative Surgical ProceduresPathway interactionsPatientsPlantsPreparationProceduresPyruvateResolutionSamplingSpecimenTherapeutic InterventionTimeTissue SampleTissuesToxic effectTracerTumor-DerivedUnited States National Institutes of HealthUrineValidationbasecancer biomarkerscancer diagnosiscancer preventioncancer recurrencecancer therapyclinical centerinstrumentationmass spectrometermetabolic imagingmetabolomicsmethod developmentnew therapeutic targetnovelnovel strategiespre-clinicalsmall moleculespectroscopic imagingstable isotopetumortumor metabolismultra high resolution
项目摘要
We have undertaken the development of facilities within Building 10 for the conduct of metabolomics studies and metabolic imaging with a focus on isotope-resolved analysis of clinical samples and patient-based studies. The Mass Spectrometry and Sample Preparation Core Facility is geared toward targeted, ultra-high resolution stable isotope-resolved metabolomics as well as careful clinical tissue sample extraction and preparation methodologies. Renovation of the laboratory spaces comprising the Mass Spectrometry and Sample Preparation Core Facility will be completed in FY20, and acquisition of analytical equipment and instrumentation is currently underway. The first mass spectrometer to be installed will be a 1,000,000 resolving power Thermo Orbitrap Fusion Lumos spectrometer equipped with a Dionex IC-6000 Ion Chromatograph and an Advion TriVersa Nanomate direct infusion electrospray ionization modules, which will be used to develop workflows tailored for targeted quantitation of approximately 120 cellular metabolites. Renovation of the space housing the Clinical NMR Metabolomics Facility was completed in November of FY20, and delivery and installation of a 700MHz Bruker NMR magnet, triple inverse resonance cryoprobe and high-capacity chilled autosampler was completed in May, 2020. Data collection and method development for NMR analysis of metabolite extracts from clinical tissue specimens obtained during surgical and biopsy procedures in the NIH Clinical Center are currently underway. Finally, procurement of a custom 13C body coil and consumables for validation and preparation of 13C1-pyruvate doses for future clinical 13C-hyperpolarized metabolic imaging are taking place.
我们已经开发了建筑物10中的设施,以进行代谢组学研究和代谢成像,重点是对临床样本和基于患者的研究的同位素分解分析。质谱和样品制备核心设施旨在实现靶向超高分辨率稳定的同位素分辨代谢组,以及仔细的临床组织样品提取和制备方法。包括质谱和样品制备核心设施的实验室空间的翻新工程将在200财年完成,目前正在收购分析设备和仪器。第一个要安装的质谱仪将是配备Dionex IC-6000离子色谱仪和Adriversa Nanomate Direct Infusion Extrospray电源电离模块的1,000,000个解决功率热Orbitrap Fusion Lumos光谱仪,该模块将用于开发用于针对目标定量的近似于120个细胞的定量工作表。临床NMR代谢组学设施的临床空间的翻新工程于11月20日完成,以及700MHz Bruker NMR磁铁的交付和安装,三重逆共振冷冻螺旋桨和高能力冰冷的冰冷的自动采样器在2020年的临床和方法中均进行了验证。 NIH临床中心的活检程序目前正在进行中。最后,正在进行定制的13C身体线圈和消耗品,以验证和制备13C1-丙酮酸剂量,以进行未来的临床13C-HYPERPARLALIZERIZER化代谢成像。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Crooks其他文献
Daniel Crooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Crooks', 18)}}的其他基金
相似国自然基金
化能自养硫氧化细菌介导的硫氧化–固氮耦合反应驱动机制及生态效应研究
- 批准号:91951118
- 批准年份:2019
- 资助金额:77.0 万元
- 项目类别:重大研究计划
海洋细菌驱动重要有机氮氧化三甲胺(TMAO)生物地球化学循环的生化过程与分子机制
- 批准号:91851205
- 批准年份:2018
- 资助金额:280.0 万元
- 项目类别:重大研究计划
接种功能内生细菌减低叶菜类蔬菜PAHs污染的效能及生理生化和分子机制
- 批准号:41771523
- 批准年份:2017
- 资助金额:63.0 万元
- 项目类别:面上项目
嗜肺军团菌OTU家族效应蛋白生化及生物学功能研究
- 批准号:31770149
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
分枝杆菌aceE基因影响细胞壁合成代谢的机制研究
- 批准号:31600107
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel approach to identify RNA-bound small molecules in vivo
体内鉴定 RNA 结合小分子的新方法
- 批准号:
10646626 - 财政年份:2023
- 资助金额:
$ 110.91万 - 项目类别:
Toward synthetic chemically defined mRNA for human therapeutics
用于人类治疗的合成化学定义的 mRNA
- 批准号:
10649299 - 财政年份:2023
- 资助金额:
$ 110.91万 - 项目类别:
A co-infection model for papillomavirus associated infections and cancers
乳头瘤病毒相关感染和癌症的共感染模型
- 批准号:
10667710 - 财政年份:2023
- 资助金额:
$ 110.91万 - 项目类别:
DeADP-ribosylation of host targets mediated by a bacterial effector
由细菌效应子介导的宿主靶标的 DeADP-核糖基化
- 批准号:
10667971 - 财政年份:2023
- 资助金额:
$ 110.91万 - 项目类别:
Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammation
阴道微生物组-代谢组关联和代谢物介导的宿主炎症的机制特征
- 批准号:
10663410 - 财政年份:2023
- 资助金额:
$ 110.91万 - 项目类别: